Back to all bills
HR 2404119th CongressIn Committee
Remote Opioid Monitoring Act of 2025
Introduced: Mar 27, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Remote Opioid Monitoring Act of 2025 would require the Comptroller General (GAO) to conduct a congressional study on the use of remote monitoring for people prescribed opioids. The study must be completed within 18 months of enactment and submitted to key House and Senate committees. The goal is to evaluate whether remote monitoring improves outcomes for opioid-treated individuals, its cost savings, how widespread such monitoring is (in the U.S. and other countries), and to propose ways to broaden access and coverage. The bill also asks for recommendations on potential changes to federal health programs to support remote monitoring and, if appropriate, to identify groups that could benefit the most.
Key Points
- 1The GAO must conduct a study within 18 months after enactment focusing on remote monitoring for individuals prescribed opioids.
- 2The report will compare outcomes and potential cost savings between those who are remotely monitored and those who are not.
- 3The study will assess current prevalence of remote monitoring, including use in other countries.
- 4The report will include recommendations to improve availability, access, and coverage for remote monitoring, including potential changes to federal health care programs (as defined in Section 1128B of the Social Security Act).
- 5If appropriate, the GAO should identify cohorts of individuals who would benefit most from remote monitoring when prescribed opioids.
Impact Areas
Primary group/area affected: Individuals prescribed opioids (patients) and the healthcare services they receive.Secondary group/area affected: Federal health care programs and policymakers evaluating coverage and access to remote monitoring.Additional impacts: Healthcare providers and payers (insurers, government programs) may use findings to guide deployment, funding decisions, and policy development; potential influence on future legislative or regulatory actions. The bill itself is a study mandate and does not create new requirements or mandalties, but its findings could shape future policy.
Generated by gpt-5-nano on Nov 1, 2025